AstraZeneca is third member to leave PhRMA in five months

AstraZeneca has decided to leave the brand drug lobbying powerhouse PhRMA halfway through the year, the organization said.

The exit is the group’s third in five months, as AbbVie exited PhRMA in December and Teva Pharmaceuticals left in February.